Nocion Therapeutics
PrivateLast Round
Early Stage
VC
Mar 13, 2026
Total Funding Raised
$127M
Momentum Score
50 /100
Company Overview
Nocion Therapeutics is a biotechnology company that develops a small molecule charged sodium channel aimed at alleviating conditions caused by neurogenic inflammation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nocion Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Nocion Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | Mar 13, 2026 | ||||
| Series B Extension | Jan 7, 2026 | ||||
| Series B | Mar 4, 2024 | ||||
| Series A | Jan 25, 2021 | ||||
| Series A | Apr 17, 2019 | ||||
Seed | Mar 1, 2018 |
Nocion Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| F-Prime Capital | Series B, Series B Extension, Series A |
| Mass General Brigham Innovation | Series B Extension, Series B, Series A |
| Mass General Brigham Ventures | Series B Extension |
| Osage University Partners | Series B, Series B Extension |
| BioInnovation Capital | Series B, Series A, Series B Extension |
| Monograph Capital | Series B, Series B Extension |
| Canaan Partners | Series B, Series A, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 7, 2026
$23M raised in Series B Extension round.
- Apr 28, 2025
Matthew Frankel, M.D., MBA appointed as Chief Medical Officer.
Nocion Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nocion Therapeutics's valuation, stock price, and market status.
